Ellevest »

Cytokinetics shares owned by Ellevest

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Ellevest from 13F filings

Historical chart of Ellevest investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Ellevest consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Ellevest

Quarter filed Position value Share count Share price at filing
2025-12-31 $211k 3.3k 63.54
2022-09-30 $1.0k 19 52.63
2022-06-30 $999 37 27.03
2021-12-31 $0 10 0.00

More positions owned by Ellevest

Vanguard Total Com Market Etf Etf (VTI)
Freedom 100 Emerging Markets Etf Etf (FRDM)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Total Bond Market Etf Etf (BND)
Ishares Esg Aware Msci Eafe Etf Etf (ESGD)
Vanguard Ftse Emerging Markets Etf Etf (VWO)
Apple (AAPL)
Ishares Esg Msci Usa Leaders Etf Etf (SUSL)
Ishares Short-term National Muni Bond Etf Etf (SUB)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares National Muni Bond Etf Etf (MUB)
Vanguard Value Etf Etf (VTV)
Vanguard Small-cap Etf Etf (VB)
Alphabet Inc Class A cs (GOOGL)

View all positions for Ellevest

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
State Street Corporation
Deep Track Capital
Geode Capital Management
Susquehanna International
Rtw Investments
Goldman Sachs Group
Polar Capital Holdings
Armistice Capital
Integral Health Asset Management
Citadel Advisors

View all funds holding Cytokinetics